Home RxNorm 1659803 azelaic acid 150 MG/ML Topical Foam [Finacea] Drug identity information. FDA.report links public drug records from RxNav, DailyMed, FDA NDC, Drugs@FDA, and related public sources where available. This page is informational only and is not medical, prescribing, or regulatory advice.
RxCUI 1659803
RxNorm name azelaic acid 150 MG/ML Topical Foam [Finacea]
Display name FINACEA (Topical)
Full name azelaic acid 150 MG/ML Topical Foam [Finacea]
Term type SBD
Status Active
Strength 15%
Dose form Foam
Route Topical
Updated 2026-10-27 17:48:21 RxNorm Status History#
Status Active
Source RXNORM
Current YES
Release start 092015
Active start 092015
Multiple ingredient NO
Branded YES Ingredients And Strength# Ingredient, Strength, Base table Ingredient Strength Base Basis of strength azelaic acid 150 MG / 1 ML azelate azelaic acid
Derived Ingredient Concepts# Ingredient, RxCUI table Ingredient RxCUI azelate 618278
FDA NDC Products And Packages# Package NDC, Product NDC, Name table Package NDC Product NDC Name Labeler Application 50222-303-50 50222-303 FINACEA FOAM azelaic acid LEO Pharma Inc. NDA207071 50222-303-91 50222-303 FINACEA FOAM azelaic acid LEO Pharma Inc. NDA207071
Drugs@FDA Applications# Application, NDC, Name table Application NDC Name Marketing category Labeler NDA207071 50222-303 FINACEA FOAM azelaic acid NDA LEO Pharma Inc.
RxNav Current And Historical NDCs# RxNav current and historical NDC rows page 1 of 1 · 6 matching rows.
NDC11, Source, Active table NDC11 Source Active 50222030350 rxnav_ndcs yes 50222030391 rxnav_ndcs yes 50419082505 rxnav_historical 50419082901 rxnav_historical 50419082971 rxnav_historical 50419082972 rxnav_historical
UNII Substances# UNII substance links page 1 of 1 · 0 matching rows.
No records found.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings# unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.
Set ID, RxNorm mappings, Terms table Set ID RxNorm mappings Terms SPL version Label Effective 9fabd24e-4c3b-49a0-aa5f-c8d75ae67572 Finacea 15 % Topical Foam [PSN] · azelaic acid 150 MG/ML Topical Foam [Finacea] [SBD] · Finacea 15 % Topical Foam [SY] · Finacea 150 MG/ML Topical Foam [SY] 4 3 These highlights do not include all the information needed to use FINACEA Foam safely and effectively. See full prescribing information for FINACEA Foam. FINACEA ® (azelaic acid) foam, for topical use Initial U.S. Approval: 1995 20201208
Recently Linked DailyMed Labels# Set ID, Title, Manufacturer table Set ID Title Manufacturer Effective 9fabd24e-4c3b-49a0-aa5f-c8d75ae67572 These highlights do not include all the information needed to use FINACEA Foam safely and effectively. See full prescribing information for FINACEA Foam. FINACEA ® (azelaic acid) foam, for topical use Initial U.S. Approval: 1995 LEO Pharma Inc. | ASM Aerosol-Service AG 20201208 d3f44051-9a13-4bcf-9783-f09286d86f4f These highlights do not include all the information needed to use FINACEA FOAM safely and effectively. See full prescribing information for FINACEA FOAM. FINACEA® (azelaic acid) Foam, 15% for topical use Initial U.S. Approval: 2015 Bayer HealthCare Pharmaceuticals Inc. | ASM Aerosol-Service AG 20190723
Properties# Category, Property, Value table Category Property Value ATTRIBUTES AVAILABLE_STRENGTH 150 MG/ML (expressed as azelaic acid) ATTRIBUTES GENERAL_CARDINALITY SINGLE ATTRIBUTES HUMAN_DRUG US ATTRIBUTES RXNAV_HUMAN_DRUG US ATTRIBUTES SCHEDULE 0 CODES NDA NDA207071 NAMES Prescribable Synonym Finacea 15 % Topical Foam SOURCES Source Gold Standard Alchemy SOURCES Source Metathesaurus FDA Structured Product Labels SOURCES Source Micromedex RED BOOK SOURCES Source Multum MediSource Lexicon